BJDX - CIK 0001704287
Bluejay Diagnostics, Inc. trades as BJDX. This page tracks Bluejay Diagnostics, Inc. through 219 SEC filings, with financial statements and metrics updated as new reports are filed.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-07 |
| Major company event | 8-K | 2026-05-07 |
The largest companies sharing Bluejay Diagnostics, Inc.'s SEC industry classification (surgical & medical instruments & apparatus).
In its latest fiscal year Bluejay Diagnostics, Inc. reported a net loss of $6.85M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.